Predictive value of individual serum neurofilament light chain levels in short-term disease activity in relapsing multiple sclerosis

被引:5
作者
Solis-Tarazona, Luis [1 ]
Raket, Lars Lau [2 ]
Cabello-Murgui, Javier [1 ]
Reddam, Salma [1 ]
Navarro-Quevedo, Silvia [3 ]
Gil-Perotin, Sara [1 ,4 ,5 ]
机构
[1] Inst Invest Sanitaria La Fe, Res Grp Immunotherapy & Biomodels Autoimmun, Valencia, Spain
[2] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden
[3] Hosp Univ & Politecn La Fe, Neurol, Valencia, Spain
[4] Hosp Univ & Politecn La Fe, Multiple Sclerosis Unit, Neurol, Valencia, Spain
[5] Inst Salud Carlos III, Consorcio Ctr Invest Biomed Red CIBER, CB06-05-1131, Madrid, Spain
关键词
multiple sclerosis; biomarker; relapse; Z-score; RMS; CEREBROSPINAL-FLUID; DISABILITY;
D O I
10.3389/fneur.2024.1354431
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background The assessment of serum neurofilament light chain (sNFL) has emerged as a diagnostic and prognostic tool in monitoring multiple sclerosis (MS). However, the application of periodic measurement in daily practice remains unclear.Objective To evaluate the predictive value of individual sNFL levels in determining disease activity in patients with relapsing MS (RMS).Methods In this two-year prospective study, 129 RMS patients underwent quarterly sNFL assessments and annual MRI scans. The study analyzed the correlation between individual NFL levels and past, current, and future disease activity. Group-level Z-scores were employed as a comparative measure.Results Among the 37 participants, a total of 61 episodes of disease activity were observed. sNFL levels proved valuable in distinct ways; they were confirmatory of previous and current clinical and/or radiological activity and demonstrated a high negative predictive value for future 90 days activity. Interestingly, Z-scores marginally outperformed sNFL levels in terms of predictive accuracy, indicating the potential for alternative approaches in disease activity assessment. In our cohort, sNFL cut-offs of 10.8 pg./mL (sensitivity 27%, specificity 90%) and 14.3 pg./mL (sensitivity 15%, specificity 95%) correctly identified 7 and 4 out of 26 cases of radiological activity within 90 days, respectively, with 14 and 15% false negatives. When using lower cut-off values, individuals with sNFL levels below 5 pg/mL (with a sensitivity of 92%, specificity of 25%, and negative predictive value of 94%) were less likely to experience radiological activity within the next 3 months.Conclusion Individual sNFL levels may potentially confirm prior or current disease activity and predict short-term future radiological activity in RMS. These findings underscore its periodic measurement as a valuable tool in RMS management and decision-making, enhancing the precision of clinical evaluation in routine practice.
引用
收藏
页数:8
相关论文
共 31 条
[1]   Renal function is associated with blood neurofilament light chain level in older adults [J].
Akamine, Shoshin ;
Marutani, Noriko ;
Kanayama, Daisuke ;
Gotoh, Shiho ;
Maruyama, Riki ;
Yanagida, Kanta ;
Sakagami, Yukako ;
Mori, Kohji ;
Adachi, Hiroyoshi ;
Kozawa, Junji ;
Maeda, Norikazu ;
Otsuki, Michio ;
Matsuoka, Takaaki ;
Iwahashi, Hiromi ;
Shimomura, Iichiro ;
Ikeda, Manabu ;
Kudo, Takashi .
SCIENTIFIC REPORTS, 2020, 10 (01)
[2]   Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS [J].
Akguen, Katja ;
Kretschmann, Nicole ;
Haase, Rocco ;
Proschmann, Undine ;
Kitzler, Hagen H. ;
Reichmann, Heinz ;
Ziemssen, Tjalf .
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2019, 6 (03)
[3]   Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis [J].
Alagaratnam, Jasmini ;
von Widekind, Sophia ;
De Francesco, Davide ;
Underwood, Jonathan ;
Edison, Paul ;
Winston, Alan ;
Zetterberg, Henrik ;
Fidler, Sarah .
BMJ NEUROLOGY OPEN, 2021, 3 (01)
[4]   Serum neurofilament-light concentration and real-world outcome in MS [J].
Anderson, Valerie ;
Bentley, Emily ;
Loveless, Sam ;
Bianchi, Lucia ;
Harding, Katharine E. ;
Wynford-Thomas, Ray A. ;
Joseph, Fady ;
Giovannoni, Gavin ;
Gnanapavan, Sharmilee ;
Robertson, Neil P. ;
Marta, Monica ;
Tallantyre, Emma C. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 417
[5]  
Barro C, 2016, MULT SCLER J, V22, P843
[6]   Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study [J].
Benkert, Pascal ;
Meier, Stephanie ;
Schaedelin, Sabine ;
Manouchehrinia, Ali ;
Yaldizli, Ozgur ;
Maceski, Aleksandra ;
Oechtering, Johanna ;
Achtnichts, Lutz ;
Conen, David ;
Derfuss, Tobias ;
Lalive, Patrice H. ;
Mueller, Christian ;
Muller, Stefanie ;
Naegelin, Yvonne ;
Oksenberg, Jorge R. ;
Pot, Caroline ;
Salmen, Anke ;
Willemse, Eline ;
Kockum, Ingrid ;
Blennow, Kaj ;
Zetterberg, Henrik ;
Gobbi, Claudio ;
Kappos, Ludwig ;
Wiendl, Heinz ;
Berger, Klaus ;
Sormani, Maria Pia ;
Granziera, Cristina ;
Piehl, Fredrik ;
Leppert, David ;
Kuhle, Jens .
LANCET NEUROLOGY, 2022, 21 (03) :246-257
[7]   Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS [J].
Bergman, Joakim ;
Dring, Ann ;
Zetterberg, Henrik ;
Blennow, Kaj ;
Norgren, Niklas ;
Gilthorpe, Jonathan ;
Bergenheim, Tommy ;
Svenningsson, Anders .
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (05)
[8]   CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis [J].
Bhan, Alok ;
Jacobsen, Cecilie ;
Dalen, Ingvild ;
Bergsland, Niels ;
Zivadinov, Robert ;
Alves, Guido ;
Myhr, Kjell-Morten ;
Farbu, Elisabeth .
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (04)
[9]   Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance [J].
Binette, Alexa Pichet ;
Janelidze, Shorena ;
Cullen, Nicholas ;
Dage, Jeffrey L. ;
Bateman, Randall J. ;
Zetterberg, Henrik ;
Blennow, Kaj ;
Stomrud, Erik ;
Mattsson-Carlgren, Niklas ;
Hansson, Oskar .
ALZHEIMERS & DEMENTIA, 2023, 19 (04) :1403-1414
[10]   The potential of serum neurofilament as biomarker for multiple sclerosis [J].
Bittner, Stefan ;
Oh, Jiwon ;
Havrdova, Eva Kubala ;
Tintore, Mar ;
Zipp, Frauke .
BRAIN, 2021, 144 :2954-2963